Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Design and Screening of Protease-Resistant Synthetic Peptides With the Anti-Tumor and Immunodulating Activity

Summary

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking capability statements from parties interested in a Cooperative Research and Development Agreement (CRADA) to design and screen protease-resistant synthetic peptides with anti-tumor and immunomodulating activity.